EpiPen's price has ballooned about 400% since 2008, rising from about a $100 list price to $500 today. The EpiPen is one of the most important life-saving medical innovations for people with severe food allergies—which affect as many as 15 million Americans and 1 in 13 children in the United States. But its price has exploded over the last decade despite few upgrades to the product itself. The product's lack of competitors is likely a significant driver of the costs. [...] [The] EpiPen enjoys a near-monopoly on the market with annual sales of more than $1.3 billion and nearly 90% U.S. market share.
(Score: 2) by driverless on Tuesday August 23 2016, @01:05PM
Price in New Zealand, about USD 87, and there's a good chance you can get the cost reimbursed by the government. Just over one tenth of the US price for the same product, if you have to pay for it at all.